BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cunningham AL, McIntyre P, Subbarao K, Booy R, Levin MJ. Vaccines for older adults. BMJ 2021;372:n188. [PMID: 33619170 DOI: 10.1136/bmj.n188] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Hägg S, Religa D. COVID vaccination in older adults. Nat Microbiol 2022. [PMID: 35836001 DOI: 10.1038/s41564-022-01166-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Alcendor DJ, Matthews-juarez P, Smoot D, Hildreth JEK, Lamar K, Tabatabai M, Wilus D, Juarez PD. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic. Vaccines 2022;10:755. [DOI: 10.3390/vaccines10050755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Soraci L, Lattanzio F, Soraci G, Gambuzza ME, Pulvirenti C, Cozza A, Corsonello A, Luciani F, Rezza G. COVID-19 Vaccines: Current and Future Perspectives. Vaccines 2022;10:608. [DOI: 10.3390/vaccines10040608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Fulop T, Larbi A, Pawelec G, Cohen AA, Provost G, Khalil A, Lacombe G, Rodrigues S, Desroches M, Hirokawa K, Franceschi C, Witkowski JM. Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change. Vaccines 2022;10:607. [DOI: 10.3390/vaccines10040607] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Veronese N, Vassallo G, Armata M, Cilona L, Casalicchio S, Masnata R, Costantino C, Vitale F, Giammanco GM, Maggi S, Sabico S, Al-daghri NM, Dominguez LJ, Barbagallo M. Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study. Vaccines 2022;10:555. [DOI: 10.3390/vaccines10040555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gil de Miguel Á, Eiros Bouza JM, Martínez Alcorta LI, Callejo D, Miñarro C, Vallejo-Aparicio LA, García A, Tafalla M, Cambronero MDR, Rodríguez R, Martin-Gomez L. Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain. Pharmacoecon Open 2022. [PMID: 35254649 DOI: 10.1007/s41669-022-00329-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mattiuzzi C, Lippi G. Efficacy of COVID-19 vaccine booster doses in older people. Eur Geriatr Med. [DOI: 10.1007/s41999-022-00615-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Bernstein CN, Singh H, Murthy SK, Nguyen GC, Benchimol EI, Bitton A, Kuenzig ME, Huang JG, Jones JL, Lee K, Targownik LE, Windsor JW, Mukhtar MS, Tandon P, Kaplan GG. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD. J Can Assoc Gastroenterol 2021;4:S34-9. [PMID: 34755037 DOI: 10.1093/jcag/gwab025] [Reference Citation Analysis]
9 Shen Y, Freeman JA, Holland J, Solterbeck A, Naidu K, Soosapilla A, Downe P, Tang C, Kerridge I, Wallman L, Van Bilsen N, Milogiannakis V, Akerman A, Martins Costa Gomes G, Sandgren K, Cunningham AL, Turville S, Mulligan SP. COVID-19 Vaccine Failure in Chronic Lymphocytic Leukemia and Monoclonal B-Lymphocytosis; Humoral and Cellular Immunity.. [DOI: 10.1101/2021.10.28.21265549] [Reference Citation Analysis]
10 Drakesmith H, Pasricha SR, Cabantchik I, Hershko C, Weiss G, Girelli D, Stoffel N, Muckenthaler MU, Nemeth E, Camaschella C, Klenerman P, Zimmermann MB. Vaccine efficacy and iron deficiency: an intertwined pair? Lancet Haematol 2021;8:e666-9. [PMID: 34450104 DOI: 10.1016/S2352-3026(21)00201-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
11 Hilmer SN, Petrovic M, Le Couteur DG, Schwartz JB, Thuermann P. Development, evaluation and use of COVID-19 vaccines in older adults: Preliminary principles for the pandemic and beyond. Br J Clin Pharmacol 2021;87:3459-61. [PMID: 34342013 DOI: 10.1111/bcp.14967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Salmerón Ríos S, Mas Romero M, Cortés Zamora EB, Tabernero Sahuquillo MT, Romero Rizos L, Sánchez-Jurado PM, Sánchez-Nievas G, Señalada JJB, García Nogueras I, Estrella Cazalla JD, Andrés-Pretel F, Murillo Romero A, Lauschke VM, Stebbing J, Abizanda P. Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study. J Am Geriatr Soc 2021;69:1441-7. [PMID: 33768521 DOI: 10.1111/jgs.17153] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 43.0] [Reference Citation Analysis]